Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
Aim. To investigate the efficacy and safety of glimepiride as initial mono-therapy in type 2 diabetes patients (T2DM). Materials and Methods. This is a multi-center, open-label prospective observational study. 245 treatment-naive T2DM patients, who had not achieved glycemic goals on lifestyle the...
Guardado en:
Autores principales: | Alexander Sergeevich Ametov, Fatima Totrazovna Abaeva |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3dd493e044804230a221fbe2dc9499dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2012) -
EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013) -
Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015) -
Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
por: Ivan Ivanovich Dedov, et al.
Publicado: (2011) -
Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)